Literature DB >> 21937655

Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography.

Tommi A White1, Alberto Bartesaghi, Mario J Borgnia, M Jason V de la Cruz, Rachna Nandwani, James A Hoxie, Julian W Bess, Jeffrey D Lifson, Jacqueline L S Milne, Sriram Subramaniam.   

Abstract

The trimeric envelope glycoprotein (Env) spikes displayed on the surfaces of simian immunodeficiency virus (SIV) and human immunodeficiency virus type 1 (HIV-1) virions are composed of three heterodimers of the viral glycoproteins gp120 and gp41. Although binding of gp120 to cell surface CD4 and a chemokine receptor is known to elicit conformational changes in gp120 and gp41, changes in quaternary structure of the trimer have only recently been elucidated. For the HIV-1 BaL isolate, CD4 attachment results in a striking rearrangement of the trimer from a "closed" to an "open" conformation. The effect of CD4 on SIV trimers, however, has not been described. Using cryo-electron tomography, we have now determined molecular architectures of the soluble CD4 (sCD4)-bound states of SIV Env trimers for three different strains (SIVmneE11S, SIVmac239, and SIV CP-MAC). In marked contrast to HIV-1 BaL, SIVmneE11S and SIVmac239 Env showed only minor conformational changes following sCD4 binding. In SIV CP-MAC, where trimeric Env displays a constitutively "open" conformation similar to that seen for HIV-1 BaL Env in the sCD4-complexed state, we show that there are no significant further changes in conformation upon the binding of either sCD4 or 7D3 antibody. The density maps also show that 7D3 and 17b antibodies target epitopes on gp120 that are on opposites sides of the coreceptor binding site. These results provide new insights into the structural diversity of SIV Env and show that there are strain-dependent variations in the orientation of sCD4 bound to trimeric SIV Env.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937655      PMCID: PMC3209358          DOI: 10.1128/JVI.05297-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

1.  EMAN: semiautomated software for high-resolution single-particle reconstructions.

Authors:  S J Ludtke; P R Baldwin; W Chiu
Journal:  J Struct Biol       Date:  1999-12-01       Impact factor: 2.867

Review 2.  Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention.

Authors:  V M Hirsch; J D Lifson
Journal:  Adv Pharmacol       Date:  2000

3.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

Review 4.  The simian immunodeficiency viruses.

Authors:  R C Desrosiers
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.

Authors:  K S Cole; M Alvarez; D H Elliott; H Lam; E Martin; T Chau; K Micken; J L Rowles; J E Clements; M Murphey-Corb; R C Montelaro; J E Robinson
Journal:  Virology       Date:  2001-11-10       Impact factor: 3.616

6.  Mitogen requirements for the in vitro propagation of cutaneous T-cell lymphomas.

Authors:  A F Gazdar; D N Carney; P A Bunn; E K Russell; E S Jaffe; G P Schechter; J G Guccion
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

7.  The stoichiometry of trimeric SIV glycoprotein interaction with CD4 differs from that of anti-envelope antibody Fab fragments.

Authors:  M Kim; B Chen; R E Hussey; Y Chishti; D Montefiori; J A Hoxie; O Byron; G Campbell; S C Harrison; E L Reinherz
Journal:  J Biol Chem       Date:  2001-09-05       Impact factor: 5.157

Review 8.  The HIV Env-mediated fusion reaction.

Authors:  Stephen A Gallo; Catherine M Finnegan; Mathias Viard; Yossef Raviv; Antony Dimitrov; Satinder S Rawat; Anu Puri; Stewart Durell; Robert Blumenthal
Journal:  Biochim Biophys Acta       Date:  2003-07-11

9.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

10.  The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.

Authors:  Stephen A Gallo; Kelly Sackett; Satinder S Rawat; Yechiel Shai; Robert Blumenthal
Journal:  J Mol Biol       Date:  2004-06-25       Impact factor: 5.469

View more
  34 in total

1.  Molecular structures of trimeric HIV-1 Env in complex with small antibody derivatives.

Authors:  Joel R Meyerson; Erin E H Tran; Oleg Kuybeda; Weizao Chen; Dimiter S Dimitrov; Andrea Gorlani; Theo Verrips; Jeffrey D Lifson; Sriram Subramaniam
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-24       Impact factor: 11.205

2.  Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.

Authors:  Olivia O'Connell; Alexander Repik; Jacqueline D Reeves; Maria Paz Gonzalez-Perez; Briana Quitadamo; Elizabeth D Anton; Maria Duenas-Decamp; Paul Peters; Rongheng Lin; Susan Zolla-Pazner; Davide Corti; Aaron Wallace; Shixia Wang; Xiang-Peng Kong; Shan Lu; Paul R Clapham
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

3.  Visualization of retroviral envelope spikes in complex with the V3 loop antibody 447-52D on intact viruses by cryo-electron tomography.

Authors:  Moumita Dutta; Jun Liu; Kenneth H Roux; Kenneth A Taylor
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

4.  Truncating the gp41 Cytoplasmic Tail of Simian Immunodeficiency Virus Decreases Sensitivity to Neutralizing Antibodies without Increasing the Envelope Content of Virions.

Authors:  Ellen White; Fan Wu; Elena Chertova; Julian Bess; James D Roser; Jeffrey D Lifson; Vanessa M Hirsch
Journal:  J Virol       Date:  2018-01-17       Impact factor: 5.103

5.  Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques.

Authors:  Philip J Santangelo; Kenneth A Rogers; Chiara Zurla; Emmeline L Blanchard; Sanjeev Gumber; Karen Strait; Fawn Connor-Stroud; David M Schuster; Praveen K Amancha; Jung Joo Hong; Siddappa N Byrareddy; James A Hoxie; Brani Vidakovic; Aftab A Ansari; Eric Hunter; Francois Villinger
Journal:  Nat Methods       Date:  2015-03-09       Impact factor: 28.547

6.  Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.

Authors:  Guiqing Hu; Jun Liu; Kenneth H Roux; Kenneth A Taylor
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

7.  Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.

Authors:  Po-Jen Yen; Alon Herschhorn; Hillel Haim; Ignacio Salas; Christopher Gu; Joseph Sodroski; Dana Gabuzda
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

Review 8.  Structural insights into key sites of vulnerability on HIV-1 Env and influenza HA.

Authors:  Jean-Philippe Julien; Peter S Lee; Ian A Wilson
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

9.  HIV-1 envelope glycoprotein trimers display open quaternary conformation when bound to the gp41 membrane-proximal external-region-directed broadly neutralizing antibody Z13e1.

Authors:  Audray K Harris; Alberto Bartesaghi; Jacqueline L S Milne; Sriram Subramaniam
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

10.  HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development.

Authors:  Mangala Rao; Kristina K Peachman; Jiae Kim; Guofen Gao; Carl R Alving; Nelson L Michael; Venigalla B Rao
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.